Janney starts Novavax at buy
Janney Capital Markets has initiated coverage of Novavax (NASDAQ:NVAX) with a “buy” rating and fair value of $11. The stock closed at $5.95 on Thursday. “The primary driver of Novavax shares is a...
View ArticleJanney starts Raptor Pharma at buy
Janney Capital Markets has launched coverage of Raptor Pharmaceuticals (NASDAQ:RPTP) with a “buy” rating and a fair value estimate of $16. The stock closed at $10.58 on Tuesday. Raptor is focused on...
View ArticleJanney starts Advaxis at buy
Janney Capital Markets has initiated coverage of Advaxis (NASDAQ:ADXS) with a “buy” rating and fair value estimate of $26. The stock closed at $18.97 on Thursday. Advaxis is built on immunotherapy...
View Article
More Pages to Explore .....